Madrigal director granted shares and stock options
Madrigal Pharmaceuticals director Daniel J. Brennan reported equity compensation awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Madrigal Pharmaceuticals director Daniel J. Brennan reported equity compensation awards. He received 404 shares of Common Stock as restricted stock units and a stock option for 681 shares at an exercise price of $499.86 per share. Both awards vest in full on the earlier of June 17, 2027 or the company’s 2027 annual stockholder meeting, if he remains in service. After these grants, Brennan directly holds 1,371 Common shares and 681 option shares.
Insider Trade Summary
Grant/Award: 1,085 shares
Grant/Award
2 txns
Insider
Brennan Daniel J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 681 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 404 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 681 contracts (Direct);
Common Stock — 1,371 shares (Direct)
Footnotes (2)
- F1. Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date.
- F2. The option vests as to 100% of underlying shares on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date.
Key Figures
Restricted stock units granted: 404 shares
Stock options granted: 681 shares
Option exercise price: $499.86 per share
+3 more
6 metrics
Restricted stock units granted
404 shares
Common Stock RSU grant on June 17, 2026
Stock options granted
681 shares
Stock Option (Right to Buy) granted on June 17, 2026
Option exercise price
$499.86 per share
Conversion or exercise price for 681-share option
Common shares after grant
1,371 shares
Total Madrigal common stock directly held after transactions
Option expiration date
June 17, 2036
Expiration of 681-share stock option position
Vesting trigger date
June 17, 2027
Earlier of this date or 2027 annual meeting for full vesting
Key Terms
restricted stock units, Stock Option (Right to Buy), exercise price, expiration date
4 terms
restricted stock units financial
"Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with 681.0000 shares and a conversion or exercise price of 499.8600"
exercise price financial
"conversion_or_exercise_price: "499.8600" for the Stock Option (Right to Buy)"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-17T00:00:00.000Z" for the Stock Option (Right to Buy)"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Daniel J. Brennan report for MDGL on this Form 4?
Daniel J. Brennan reported two equity compensation grants: 404 shares of Madrigal Pharmaceuticals common stock as restricted stock units and a stock option covering 681 shares, both awarded at no cash cost to him on June 17, 2026.
What are the terms of Daniel Brennan’s new MDGL stock option grant?
The new stock option covers 681 shares of Madrigal common stock at an exercise price of $499.86 per share and expires on June 17, 2036, contingent on the vesting schedule described in the Form 4 footnotes.
When do Daniel Brennan’s MDGL restricted stock units and options vest?
Both the 404-share restricted stock unit grant and the 681-share stock option vest 100% on the earlier of June 17, 2027 or Madrigal’s 2027 annual meeting, provided Brennan continues in service with the company through that vesting date.
Is Daniel Brennan’s MDGL Form 4 transaction a market purchase or sale?
The Form 4 shows grant or award acquisitions, not open-market trades. Brennan did not buy or sell shares on the market; he received restricted stock units and stock options as compensation, at a reported price of $0.00 per share for the grants.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates